Detailed View
BIO - Bio-Rad Laboratories, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
10,268,795,904
Adj EBIT (TTM)
228,700,000
Enterprise Value
9,462,195,904
Last Price
384.05
Earnings Yield
2.42%
Return on Capital
2.67%
Capital
8,556,400,000
1Y Price Chart
Last Price: $384.05
1Y Change: 16.23%
As of 2026-10-29 | 1Y Change: 16.23%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 651,000,000 | 72,600,000 |
| 2026-03-31 | 10-Q | 2026 | 592,100,000 | 34,100,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 693,200,000 | 53,900,000 |
| 2025-09-30 | 10-Q | 2025 | 653,000,000 | 65,300,000 |
| 2025-06-30 | 10-Q | 2025 | 651,600,000 | 77,100,000 |
| 2025-03-31 | 10-Q | 2025 | 585,400,000 | 23,700,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 667,524,000 | 58,330,000 |
| 2024-09-30 | 10-Q | 2024 | 649,700,000 | 64,466,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.